AlzChem Group AG (ALZCF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
AlzChem Group AG (ALZCF) trades at $185.70 with AI Score 47/100 (Grade C). AlzChem Group AG develops, produces, and trades a diverse portfolio of specialty chemical products globally, serving sectors like nutrition, agriculture, pharmaceuticals, and advanced materials. Market cap: $1.88B, Sector: Basic materials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for ALZCF: ALZCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ALZCF against Basic Materials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
ALZCF: the 1 perspectives are evenly split.
How is this calculated? →AlzChem Group AG (ALZCF) Materials & Commodity Exposure
AlzChem Group AG is a German specialty chemicals manufacturer with a century-long history, producing a broad range of products from dietary supplements and feed additives to advanced materials and industrial chemicals. The company serves diverse global markets, leveraging its expertise in calcium carbide-based chemistry to maintain a significant presence in niche applications.
What Is the Investment Thesis for ALZCF?
AlzChem Group AG presents an investment profile centered on its diversified specialty chemicals portfolio and established market positions. With a market capitalization of $1.88B and a P/E ratio of 28.07, the company demonstrates profitability with an 11.8% profit margin and a 23.8% gross margin. Its low Beta of 0.58 suggests relatively stable performance compared to the broader market. Growth catalysts include increasing global demand for high-quality dietary supplements and feed additives, expansion in advanced materials for electronics and renewable energy, and sustained demand for fine chemicals in pharmaceutical and agricultural sectors. The company's long operational history since 1908 and broad geographic reach across Europe, Asia, and NAFTA provide a stable foundation. However, as an OTC Other stock, liquidity risk is a notable factor. Investors should monitor ongoing developments in specialty chemical markets and the company's financial disclosures for sustained performance and strategic initiatives.
Based on FMP financials and quantitative analysis
ALZCF Key Highlights
- Market capitalization of $1.88B reflects its substantial presence in the specialty chemicals sector.
- P/E ratio of 28.07 indicates investor confidence in its earnings potential relative to its industry peers.
- Profit margin of 11.8% demonstrates efficient management and strong profitability within its diverse operations.
- Gross margin of 23.8% highlights the company's ability to maintain healthy margins on its specialized chemical products.
- Beta of 0.58 suggests lower volatility compared to the overall market, offering a degree of stability for investors.
Who Are ALZCF's Competitors?
ALZCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| HGRAF HydroGraph Clean Power Inc. | $3.43 | -3.11% | $1.20B | 69 |
| LWLG Lightwave Logic, Inc. | $7.46 | +1.29% | $1.15B | 69 |
| COOSF Carbios SAS | $6.50 | -9.09% | $109.66M | 69 |
| NVZMY Novozymes A/S | $63.45 | -2.53% | $29.58B | 62 |
| ELKEF Elkem ASA | $3.40 | +0.00% | $2.16B | 50 |
| GVDBF Givaudan S.A. | $3440.15 | -18.91% | $31.75B | 50 |
| AVNT Avient Corporation | $38.83 | +4.07% | $3.56B | 50 |
| HWKN Hawkins, Inc. | $139.44 | +0.69% | $2.92B | 50 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ALZCF's Key Strengths?
- Diversified product portfolio serving multiple high-growth industries (nutrition, electronics, agriculture, pharma).
- Strong brand recognition for key products like Creapure, Alipure, and DYHARD.
- Long operational history since 1908, indicating deep industry expertise and resilience.
- Global geographic reach across Europe, Asia, and NAFTA regions.
- Healthy financial metrics including an 11.8% profit margin and 23.8% gross margin.
What Are ALZCF's Weaknesses?
- Operating as an OTC Other stock, which typically implies lower liquidity and less stringent disclosure requirements.
- Reliance on calcium carbide-based chemistry, which may be subject to raw material price fluctuations.
- Potential for intense competition from larger, more diversified chemical companies.
- Exposure to regulatory changes in diverse end-markets such as food, feed, and pharmaceuticals.
What Could Drive ALZCF Stock Higher?
- Continued growth in global demand for dietary supplements and functional foods, boosting sales of Creapure and Alipure brands.
- Expansion of applications for silicon nitride (SILZOT) in high-growth sectors like electric vehicles, advanced electronics, and solar energy.
- Increased adoption of specialized curing agents (DYHARD) in the automotive and aerospace industries for lightweight composite materials.
- Strategic initiatives to enhance production efficiency and reduce operational costs, improving profit margins.
- Development of new, environmentally friendly agricultural solutions to meet evolving market demands for sustainable farming.
What Are the Key Risks for ALZCF?
- Volatility in raw material prices, particularly for calcium carbide and energy, impacting production costs and profitability.
- Liquidity risk associated with trading on the OTC Other market, potentially leading to wider bid-ask spreads and difficulty in trading shares.
- Intensified competition from larger chemical companies or new market entrants, leading to pricing pressures.
- Regulatory changes in the various industries it serves (e.g., food, feed, pharmaceuticals, environmental) could impact product formulations or market access.
- Economic downturns in key geographic markets (Europe, Asia, NAFTA) reducing demand for industrial and specialty chemicals.
What Are the Growth Opportunities for ALZCF?
- **Expansion in Human and Animal Nutrition:** The global demand for dietary supplements and high-performance feed additives continues to grow, driven by increasing health consciousness and the need for efficient animal protein production. AlzChem's Creapure, Alipure, LIVADUR, and Creamino brands are well-positioned to capitalize on this trend. The market for creatine alone is expanding, with consumers seeking proven benefits for athletic performance and general well-being. Expanding distribution channels and product innovation within this segment could significantly boost revenue, leveraging the company's established reputation for purity and quality.
- **Advanced Materials for Electronics and Renewables:** The SILZOT brand of silicon nitride caters to high-growth sectors like ceramics, electronics, and solar applications. As industries increasingly demand materials with superior thermal, mechanical, and electrical properties, silicon nitride's role in advanced manufacturing becomes critical. The ongoing global push for renewable energy and miniaturization in electronics creates a sustained demand for such specialized materials. AlzChem can leverage its expertise to develop new applications or enhance existing products, securing a larger share in these technologically advanced markets.
- **Specialty Curing Agents for High-Performance Composites:** AlzChem's DYHARD curing agents are essential components in adhesives, powder coatings, printed circuit boards, and composites. The automotive, aerospace, and construction industries are increasingly adopting lightweight, durable, and high-performance materials, driving demand for advanced curing agents. As these industries continue to innovate and seek improved material properties, AlzChem's specialized offerings can capture a growing market share. Strategic partnerships with manufacturers and continuous product development to meet evolving industry standards represent a significant growth pathway.
- **Fine Chemicals for Pharmaceutical Intermediates:** The Bioselect brand and other fine chemicals derived from calcium carbide and its derivatives serve the pharmaceutical industry as crucial intermediates. The global pharmaceutical market is characterized by continuous innovation, drug development, and a need for high-purity, reliable chemical components. AlzChem's ability to produce complex organic and inorganic fine chemicals positions it as a valuable supplier. Expanding its portfolio of pharmaceutical-grade intermediates and strengthening relationships with drug manufacturers could unlock substantial growth, driven by the consistent demand for new and existing medications.
- **Sustainable Agricultural Solutions:** Products like PERLKA (calcium cyanamide), ALZOGUR (germicide), Dormex, Sitofex (plant growth regulators), and BREAK-THRU (plant protection additives) address critical needs in modern agriculture and animal husbandry. With increasing global population and environmental concerns, there is a growing emphasis on sustainable farming practices, improved crop yields, and animal health. AlzChem's offerings contribute to these goals by enhancing soil fertility, controlling pathogens, and optimizing plant growth. Developing new, environmentally friendly formulations and expanding market penetration in emerging agricultural economies represent key growth avenues.
What Opportunities Does ALZCF Have?
- Increasing global demand for high-quality dietary supplements and functional feed additives.
- Growing adoption of advanced materials like silicon nitride in electronics, solar, and high-performance ceramics.
- Expansion into new applications for specialty curing agents in evolving composite and coating markets.
- Leveraging expertise in fine chemicals to meet rising demand from the pharmaceutical industry.
- Developing sustainable agricultural solutions to address global food security and environmental concerns.
What Threats Does ALZCF Face?
- Economic downturns impacting industrial demand for specialty chemicals.
- Volatile raw material costs, particularly for calcium carbide and energy.
- Intensified competition leading to pricing pressures and margin erosion.
- Regulatory changes or new environmental standards impacting production processes or product formulations.
- Technological advancements by competitors that could disrupt existing product lines.
What Are ALZCF's Competitive Advantages?
- Proprietary manufacturing processes and deep expertise in calcium carbide-based chemistry, developed over a century.
- Strong brand recognition for key products like Creapure (dietary supplements) and DYHARD (curing agents), indicating product quality and market trust.
- Diversified product portfolio serving multiple critical industries, reducing reliance on any single market segment.
- Global sales and distribution network, providing broad market access and resilience.
- Integrated operations from basic intermediates to finished specialty products, potentially offering cost efficiencies and quality control.
What Does ALZCF Do?
AlzChem Group AG, founded in 1908 and headquartered in Trostberg, Germany, has evolved into a global developer, producer, and trader of a wide array of chemical products. The company operates through three primary segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding, demonstrating a diversified approach to the chemical industry. Its product portfolio is extensive, catering to various end-markets including human and animal nutrition, pharmaceuticals, agriculture, and advanced materials. Key offerings include dietary supplements such as Creapure and Alipure, and the creatine-based LIVADUR brand, alongside nutritional feed additives like Creamino. For industrial applications, AlzChem provides high-performance materials such as DYHARD curing agents for adhesives, powder coatings, and composites, and SILZOT silicon nitride for ceramics, electronics, and solar technologies. The company also specializes in fine and specialty chemicals derived from calcium carbide, calcium cyanamide, and their derivatives, which are crucial intermediates for various industries. Agricultural products under brands like PERLKA (calcium cyanamide), ALZOGUR (germicide), Dormex and Sitofex (plant growth regulators), and BREAK-THRU (plant protection additives) further highlight its diversified market reach. Beyond product manufacturing, AlzChem Group AG is involved in hot metal desulfurization, secondary metallurgy applications, and the provision of technical gases. The company also manages chemical park operations and administrative services, including infrastructure services, underscoring its integrated operational model and broad geographic footprint across Germany, the European Union, the rest of Europe, Asia, and the NAFTA region.
What Products and Services Does ALZCF Offer?
- Develop, produce, and trade a wide range of chemical products globally.
- Manufacture dietary supplements under brands like Creapure, Alipure, and LIVADUR.
- Produce nutritional feed additives, including guanidinoacetic acid under the Creamino brand.
- Offer curing agents (DYHARD) for adhesives, powder coatings, printed circuit boards, and composites.
- Supply silicon nitride (SILZOT) for ceramics, electronics, and solar applications.
- Provide fine and specialty chemicals based on calcium carbide, cyanamide, and their derivatives.
- Produce agricultural products such as calcium cyanamide (PERLKA), germicides (ALZOGUR), and plant growth regulators (Dormex, Sitofex).
- Offer products for hot metal desulfurization, secondary metallurgy, and technical gases.
How Does ALZCF Make Money?
- Revenue generation through the sale of a diverse portfolio of specialty chemical products to various industries.
- Operating through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding, indicating diversified revenue streams.
- Leveraging proprietary production processes and brand recognition for key products like Creapure and DYHARD.
- Providing chemical park operations and administrative/infrastructure services, contributing to overall revenue and operational efficiency.
- Global sales and distribution network across Germany, EU, rest of Europe, Asia, and NAFTA regions.
What Industry Does ALZCF Operate In?
AlzChem Group AG operates within the Chemicals - Specialty industry, a segment of the broader Basic Materials sector characterized by high-value-added products tailored for specific applications. This industry is driven by innovation, stringent quality requirements, and evolving demand from diverse end-markets such as nutrition, automotive, electronics, and agriculture. AlzChem's focus on calcium carbide-based chemistry and its derivatives positions it uniquely, allowing it to produce a range of fine chemicals, advanced materials, and performance additives. The global specialty chemicals market is experiencing growth due to increasing industrialization, technological advancements, and a rising focus on sustainable and high-performance solutions. AlzChem competes with both large multinational chemical conglomerates and smaller, specialized players, differentiating itself through its proprietary production processes, brand recognition for products like Creapure and DYHARD, and its integrated value chain from basic intermediates to finished specialty products.
Who Are ALZCF's Key Customers?
- Consumers of dietary supplements and health products.
- Animal feed manufacturers and agricultural businesses.
- Manufacturers in the adhesives, coatings, and composite industries.
- Companies in the electronics, solar, and advanced ceramics sectors.
- Pharmaceutical companies requiring fine chemical intermediates.
Company Profile
AlzChem Group AG operates in the Chemicals - Specialty industry within the Basic Materials sector. It is headquartered in Trostberg, DE. The company is led by CEO Andreas Niedermaier. ALZCF has traded publicly since 2021.
ROE 27%Key Financial Metrics
Return on equity for AlzChem Group AG stands at 27.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 10.2%, showing how much profit it generates from its asset base. ALZCF trades at a trailing price-to-earnings ratio of 28.07, above the Basic Materials sector average of ~22x. Its free cash flow yield is 1.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.26 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 3.6%, the inverse of the P/E and a quick read on earnings relative to price.
ALZCF Valuation & Market Position
With a $1.88B market cap, AlzChem Group AG sits in the small-cap segment of the market. Relative to its peer group, ALZCF's quantitative score of 47/100 is below the peer average of 64/100.
Quarterly Financial Performance: AlzChem Group AG
Revenue for AlzChem Group AG came in at $149.2M during Q1 2026, a 9.1% improvement versus the preceding quarter. The company recorded net income of $18.0M, with diluted EPS of $1.78. Quarter-over-quarter revenue has been mixed, typical for a small-cap company operating in Basic Materials. Across the four most recent quarters, ALZCF averaged $1.65 in diluted EPS.
F-Score 4/9Financial Health
AlzChem Group AG's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.22 places it in the safe zone, indicating low near-term bankruptcy risk.
FY2026 estForward Outlook
Wall Street analysts project AlzChem Group AG revenue of about $604.3M for fiscal 2026, with EPS near $6.57. The estimate reflects 7 contributing analysts.
ALZCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future performance, indicating that leadership believes in the growth potential.
- Community sentiment has shifted positively, with discussions highlighting AlzChem's innovations in specialty chemicals and their applications in various industries.
- The company's strategic partnerships are gaining attention, positioning it well within the market and enhancing its competitive edge.
- Investors are optimistic about AlzChem's sustainability initiatives, aligning with broader market trends towards environmentally friendly practices.
Bear Case
- Concerns about the volatility in raw material prices could impact profit margins, leading to uncertainty among investors.
- Recent discussions in the community reflect skepticism regarding the company's ability to scale its operations effectively amidst increasing competition.
- Market perception has been cautious due to potential regulatory challenges in the chemical industry, raising red flags for some investors.
- The overall economic environment remains uncertain, which has led to a bearish outlook among some traders regarding discretionary spending on specialty chemicals.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · April 2026
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $149M | $18M | $1.78 |
| Q4 2025 | $137M | $17M | $1.65 |
| Q3 2025 | $138M | $16M | $1.61 |
| Q2 2025 | $143M | $16M | $1.57 |
Based on FMP financials and quantitative analysis
ALZCF Latest News
No recent news available for ALZCF.
ALZCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALZCF.
Price Targets
Wall Street price target analysis for ALZCF.
ALZCF MoonshotScore
What does this score mean?
The MoonshotScore rates ALZCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andreas Niedermaier
Managing Director (CEO)
Andreas Niedermaier serves as the Managing Director of AlzChem Group AG, leading a workforce of 1541 employees. His leadership is central to the company's strategic direction and operational execution across its diverse chemical product segments. While specific details on his educational background and prior roles are not provided in the source, his position at the helm of a long-established and globally operating specialty chemicals company suggests a significant career trajectory within the industry or related fields, accumulating extensive experience in management, production, and international business.
Track Record: Under Andreas Niedermaier's leadership, AlzChem Group AG continues to develop, produce, and trade a broad portfolio of chemical products across international markets. His tenure has seen the company maintain its market position in key segments such as dietary supplements, feed additives, and specialty industrial chemicals. The company's consistent profitability, as evidenced by its 11.8% profit margin, reflects effective management and strategic decision-making in navigating the complexities of the global chemical industry.
ALZCF OTC Market Information
AlzChem Group AG trades on the OTC Other tier, which is the lowest tier of the OTC market. Unlike stocks listed on major exchanges like NYSE or NASDAQ, which adhere to strict listing requirements regarding financial reporting and corporate governance, OTC Other securities have minimal to no reporting requirements with the SEC. This tier typically includes companies that do not meet the standards for OTCQX or OTCQB, or choose not to provide financial disclosures. Consequently, investors face greater challenges in obtaining timely and comprehensive financial information, which can impact investment decisions.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower liquidity and wider bid-ask spreads compared to exchange-listed stocks, making trading more difficult.
- Limited public financial disclosure, as the company's disclosure status is 'Unknown', hindering comprehensive due diligence.
- Increased susceptibility to price manipulation due to lower trading volumes and less regulatory oversight.
- Difficulty in obtaining reliable and timely information, which can lead to information asymmetry.
- Potential for reduced institutional investor interest due to perceived higher risk and lack of transparency.
- Verify the company's latest financial statements directly from their investor relations website or official filings, if available.
- Research any news releases or corporate announcements from the company itself, rather than relying solely on third-party sources.
- Assess the trading volume and bid-ask spread over a sustained period to understand liquidity characteristics.
- Investigate the company's management team and corporate governance practices, looking for transparency and accountability.
- Understand the regulatory environment in Germany and the EU, where the company is headquartered and primarily operates.
- Evaluate the company's competitive landscape and market position based on available industry reports and company data.
- Consider the impact of foreign exchange rates on the company's financials, given its international operations.
- Long operational history since 1908, indicating established business operations and resilience.
- Headquartered in Trostberg, Germany, a developed market with established corporate governance norms.
- Operates globally across Germany, EU, rest of Europe, Asia, and NAFTA, suggesting a broad and active business.
- Manages a significant workforce of 1541 employees, indicating a substantial operational footprint.
- Produces a diverse range of branded chemical products (e.g., Creapure, DYHARD, PERLKA), suggesting tangible assets and market presence.
Common Questions About ALZCF (Basic Materials)
What does AlzChem Group AG do?
AlzChem Group AG is a German specialty chemicals company that develops, produces, and trades a wide range of chemical products internationally. Its operations are segmented into Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company's diverse product portfolio includes dietary supplements (Creapure, LIVADUR), nutritional feed additives (Creamino), high-performance curing agents (DYHARD), and silicon nitride for advanced materials (SILZOT). Additionally, it manufactures fine chemicals, agricultural products like PERLKA, and provides solutions for metallurgy and technical gases, serving a broad spectrum of industries from nutrition to electronics and agriculture across Europe, Asia, and the NAFTA region.
What are the key financial metrics investors watch for ALZCF?
For AlzChem Group AG, investors typically monitor several key financial metrics to assess its performance and valuation. The P/E ratio of 28.07 provides insight into how much investors are willing to pay for each dollar of earnings. Profit margin (11.8%) and gross margin (23.8%) are crucial for understanding the company's operational efficiency and pricing power within the specialty chemicals sector. Its market capitalization of $1.88B indicates its overall size. Given its industry, investors also watch for revenue growth, capital expenditure related to production expansion, and cash flow generation, which are vital for a capital-intensive business. The dividend yield of 1.11% is also relevant for income-focused investors.
What are the main risks for ALZCF?
The primary risks for AlzChem Group AG include its status as an OTC Other stock, which entails significant liquidity risk due to lower trading volumes and potentially wider bid-ask spreads, making it difficult to trade shares efficiently. The company also faces potential volatility in raw material costs, particularly for calcium carbide and energy, which can impact its profit margins. Intense competition within the specialty chemicals market from larger, more diversified players could lead to pricing pressures. Furthermore, regulatory changes in the diverse industries it serves, such as food, feed, pharmaceuticals, and environmental regulations, pose ongoing compliance and operational risks.
How does AlzChem Group AG position itself in the specialty chemicals market?
AlzChem Group AG positions itself as a specialized provider leveraging its deep expertise in calcium carbide-based chemistry, a foundation laid over a century ago. This allows the company to produce a unique range of fine chemicals, advanced materials, and performance additives tailored for specific, high-value applications. Its strategy involves diversification across critical sectors like human and animal nutrition, advanced materials (electronics, solar), pharmaceuticals, and agriculture. By offering branded products such as Creapure for dietary supplements and DYHARD for curing agents, AlzChem differentiates itself through quality, purity, and application-specific solutions, maintaining a strong presence in niche markets globally rather than competing broadly on commodity chemicals.
What are the key factors to evaluate for ALZCF?
AlzChem Group AG (ALZCF) holds an AI score of 47/100 (low). Not financial advice.
How frequently does ALZCF data refresh on this page?
ALZCF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven ALZCF's recent stock price performance?
AlzChem Group AG (ALZCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified product portfolio serving multiple high-growth industries (nutrition, electronics, agriculture, pharma). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider ALZCF overvalued or undervalued right now?
Valuing AlzChem Group AG (ALZCF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.